Early Career Research Prize in Vaccinology R&D – 2nd edition

2018 05 03 Written by Vaccines Europe

The Early Career Research Prize in Vaccinology R&D is awarded by the International Union of Immunological Societies (IUIS) with the contribution of Vaccines Europe. The objective is to promote and foster a younger generation of scientists in the early stages of their career.

The prize rewards significant achievements in Vaccine R&D, including the discovery of new vaccine antigens, new vaccines design, understanding the basics of the immune response, new technologies that will improve the future of vaccines and vaccination and that are supported by proof-of-concept data (preclinical and clinical).

For information regarding application criteria, follow this link and the Promotion Flyer.

IMI: celebrating 10 years of medical innovations

2018 05 02 Written by Vaccines Europe

The Innovative Medicines Initiative (IMI) is celebrating its 10th anniversary with a high-level event. Organised jointly by IMI together with the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA), the event will take place at the European Commission’s Charlemagne Building in Brussels, Belgium on Wednesday 27 June 2018 from 13:00 to 18:00.

Read more…

Vaccines Europe statement on the European Commission Proposal for a Council Recommendation on Strengthened Cooperation against Vaccine Preventable Diseases

2018 04 26 Written by Vaccines Europe

Vaccines Europe welcomes the European Commission Proposal for a Council Recommendation and the Commission Communication on Strengthened Cooperation against Vaccine Preventable Diseases. See the full statement here.

European Immunisation Week 2018 – vaccination as an individual right and shared responsibility

2018 04 23 Written by Vaccines Europe

Vaccines Europe welcomes the European region 14th European Immunisation Week (EIW) focused on “vaccines as an individual right and shared responsibility, to help close immunisation gaps”. Access the full statement here.

See all News